5-13886135-CAAAAAAAAAA-CAAAAAAAAAAA
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_001369.3(DNAH5):c.2578-7dupT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.021 ( 65 hom., cov: 0)
Exomes 𝑓: 0.019 ( 8 hom. )
Consequence
DNAH5
NM_001369.3 splice_region, intron
NM_001369.3 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.0110
Genes affected
DNAH5 (HGNC:2950): (dynein axonemal heavy chain 5) This gene encodes a dynein protein, which is part of a microtubule-associated motor protein complex consisting of heavy, light, and intermediate chains. This protein is an axonemal heavy chain dynein. It functions as a force-generating protein with ATPase activity, whereby the release of ADP is thought to produce the force-producing power stroke. Mutations in this gene cause primary ciliary dyskinesia type 3, as well as Kartagener syndrome, which are both diseases due to ciliary defects. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 5-13886135-C-CA is Benign according to our data. Variant chr5-13886135-C-CA is described in ClinVar as [Likely_benign]. Clinvar id is 1269037.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0602 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAH5 | NM_001369.3 | c.2578-7dupT | splice_region_variant, intron_variant | ENST00000265104.5 | NP_001360.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAH5 | ENST00000265104.5 | c.2578-7dupT | splice_region_variant, intron_variant | 1 | NM_001369.3 | ENSP00000265104.4 | ||||
DNAH5 | ENST00000681290.1 | c.2533-7dupT | splice_region_variant, intron_variant | ENSP00000505288.1 | ||||||
ENSG00000251423 | ENST00000503244.2 | n.254-10435dupA | intron_variant | 4 | ||||||
ENSG00000251423 | ENST00000637153.1 | n.214-10435dupA | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0209 AC: 2583AN: 123802Hom.: 65 Cov.: 0
GnomAD3 genomes
AF:
AC:
2583
AN:
123802
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0376 AC: 2316AN: 61536Hom.: 8 AF XY: 0.0361 AC XY: 1132AN XY: 31394
GnomAD3 exomes
AF:
AC:
2316
AN:
61536
Hom.:
AF XY:
AC XY:
1132
AN XY:
31394
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0188 AC: 22720AN: 1205682Hom.: 8 Cov.: 0 AF XY: 0.0188 AC XY: 11187AN XY: 595948
GnomAD4 exome
AF:
AC:
22720
AN:
1205682
Hom.:
Cov.:
0
AF XY:
AC XY:
11187
AN XY:
595948
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0209 AC: 2583AN: 123780Hom.: 65 Cov.: 0 AF XY: 0.0206 AC XY: 1211AN XY: 58676
GnomAD4 genome
AF:
AC:
2583
AN:
123780
Hom.:
Cov.:
0
AF XY:
AC XY:
1211
AN XY:
58676
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Primary ciliary dyskinesia Benign:2
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 27, 2019 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 07, 2015 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 15, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at